C WorldWide Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

C WorldWide Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-311,544	Closed	-$36M	–	89
2023 Q3	$36M	Sell	311,544 -100,000	-24%	-$10.7M	0.49%	21
2023 Q2	$42.3M	Hold	411,544	–	–	0.55%	22
2023 Q1	$44.9M	Hold	411,544	–	–	0.62%	19
2022 Q4	$46.8M	Hold	411,544	–	–	0.62%	19
2022 Q3	$25.5M	Buy	411,544 +100,000	+32%	+$6.99M	0.35%	25
2022 Q2	$24.8M	Hold	311,544	–	–	0.31%	24
2022 Q1	$32.8M	Buy	311,544 +40,000	+15%	+$3.9M	0.36%	23
2021 Q4	$29.3M	Sell	271,544 -25,000	-8%	-$2.73M	0.28%	26
2021 Q3	$32.5M	Sell	296,544 -30,000	-9%	-$3.11M	0.33%	23
2021 Q2	$30.6M	Sell	326,544 -100,000	-23%	-$9.2M	0.32%	25
2021 Q1	$39.3M	Sell	426,544 -40,000	-9%	-$3.38M	0.38%	23
2020 Q4	$34.1M	Buy	+466,544	New	+$34.7M	0.34%	29
2019 Q3	–	Sell	-491,544	Closed	-$11.8M	–	84
2019 Q2	$11.8M	Buy	491,544 +300,000	+157%	+$7.61M	0.15%	50
2019 Q1	$5.06M	Hold	191,544	–	–	0.06%	56
2018 Q4	$3.74M	Sell	191,544 -159,805	-45%	-$3.13M	0.05%	56
2018 Q3	$6.88M	Sell	351,349 -64,136	-15%	-$1.22M	0.09%	53
2018 Q2	$6.88M	Buy	415,485 +134,185	+48%	+$2.05M	0.1%	51
2018 Q1	$3.99M	Sell	281,300 -61,594	-18%	-$910K	0.06%	59
2017 Q4	$5.01M	Sell	342,894 -40,254	-11%	-$565K	0.07%	58
2017 Q3	$4.86M	Sell	383,148 -5,136	-1%	-$65.3K	0.07%	64
2017 Q2	$4.61M	Buy	388,284 +57,575	+17%	+$716K	0.07%	65
2017 Q1	$4.89M	Buy	330,709 +47,069	+17%	+$762K	0.08%	53
2016 Q4	$4.59M	Sell	283,640 -463,960	-62%	-$8.41M	0.09%	58
2016 Q3	$13.6M	Buy	747,600 +82,600	+12%	+$1.61M	0.24%	35
2016 Q2	$11M	Buy	665,000 +3,500	+0.5%	+$56.6K	0.21%	38
2016 Q1	$11M	Hold	661,500	–	–	0.21%	37
2015 Q4	$14.3M	Buy	+661,500	New	+$12.9M	0.25%	35

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

C WorldWide Group's HZNP Position: Q4 2023 in Review

C WorldWide Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 311,544 shares — an estimated $36M sold.

C WorldWide Group first reported a position in HZNP in Q4 2015 and held it in 27 quarters. The position peaked at $46.8M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

C WorldWide Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
C WorldWide Group sold 311,544 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $36M.
C WorldWide Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and held it in 27 quarters.
C WorldWide Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $46.8M in Q4 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on C WorldWide Group's 13F filing for Q4 2023, filed 5 Feb 2024.